Five Years on, 3.9 Million People in the Developing World Have Access to HIV Treatment Dolutegravir, Thanks to Access-oriented Voluntary Licensing Agreements
Advertisement
The Medicine Patent Pool and ViiV Healthcare highlight how innovative licensing agreements continue to provide access to dolutegravir in an unprecedented timeframe